2 May 2025

Gene Therapy Process Development Support to Optimize AAV Yield & Quality from Gene to GMP Production

Read More

2 May 2025

Gene Therapy Formulation

Read More

2 May 2025

Analytics-driven AAV Development & Manufacturing

Read More

2 May 2025

ABL Viral Vector Manufacturing Experts

Read More

2 May 2025

ABL Drug Product Fill/Finish Services

Read More

21 January 2025

Recombinant AAV batch profiling by nanopore sequencing elucidates product-related DNA impurities and vector genome length distribution

Read More

14 January 2025

Polo-like kinase inhibitors increase AAV production by halting cell cycle progression

Read More

17 November 2024

Transcriptomics-informed pharmacology identifies epigenetic and cell cycle regulators that enhance AAV production

Read More

15 October 2024

From chemical to mechanical: A comparative analysis of cell lysis strategies for mammalian cells

Read More

15 October 2024

Considerations for AAV analytical comparability studies for products with low batch numbers

Read More

15 October 2024

Two for one: A single QC assay to quantify two plasmid impurities (cap/kanR) across a number of serotypes reduces time & costs for rAAV batch release

Read More

15 October 2024

Streamlined pre-formulation screening with minimal sample requirements & ​2-day turnaround to enable high efficiency ​AAV formulation development

Read More